Implication of genetic and clinical factors in the generation of antibodies against Adalimumab in patients with uveitis: Towards the description of biomarkers of therapeutic response.

Project: Research Project

Project Details

Description

General objective
Formulate the risk factors associated with the development of anti-drug antibodies in patients with non-infectious uveitis treated with adalimumab.

Specific objectives (clinical phase)
•Sociodemographic characterization of patients with non-infectious uveitis treated with adalimumab in two uveitis centers.

•To determine the frequency of anti-adalimumab (AAA+) antibodies in patients with non-infectious uveitis treated with adalimumab.

Keywords

Anti-drug antibodies, anti-Adalimumab antibodies, next generation sequencing, auto-antibodies, uveitis, adalimumab.
StatusActive
Effective start/end date8/29/238/29/24

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Main Funding Source

  • Competitive Funds
  • Seed Capital

Location

  • Bogotá D.C.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.